Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits

Cardiovascular Drugs and Therapy

Volumn 11, Issue 4, 1997, Pages 575-590

  Singh, Ram B ^a,d   Singh, Nand K ^a   Rastogi, Shanti S ^a   Wander, Gurpreet S ^a   Aslam, Mohammad ^a   Onouchi, Zenshiro ^b   Kummerow, Fred A ^c   Nangia, S ^a  

^a Medical Hospital and Research Centre Moradabad   (India)

^b Children's Research Hospital   (Japan)

^c Burnsides Research Laboratory   (United States)

^d Heart Research Laboratory   (India)

Author keywords

Lipoproteins; Lovastatin; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; FATTY ACID; FREE RADICAL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEATH; FAT INTAKE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 0030869646     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007787721410     Document Type: Article

References (24)

1. Lovastatin Study Groups I through IV. Lovastatin 5 year safety and efficacy study. Arch Intern Med 1993;153: 1079-1087.
2. Bradford RH, Shear CL, Chremos AN. Expanded clinical evaluation of lovastatin (EXCEL) study results: Two year efficacy and safety follow-up. Am J Cardiol 1994;74:667-673.
3. Henwood JM, Heel RC, Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidemia. Drugs 1988;36:429-454.
4. Lovastatin Study Group IV. A multicentre comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. Am J Cardiol 1990;66:22B-30B.
5. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypocholesterolemia. Cardiovasc Drug Ther 1994;8:659-664.
6. Carew T, Schwenke D, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect, evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci USA 1987;84:7725-7729.
7. Witztum JL. The oxidative hypothesis of atheroselerosis. Lancet 1994;344:793-795.
8. Niato C. Kawamura M, Yamamoto Y. Lipid peroxides as the initiating factor of atherosclerosis. Ann N Y Acad Sci 1993;676:27-45.
9. Anderson TJ, Meridith IT, Yeung AC. The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-493.
10. Smith TL, Kummerow FA. Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted anovulatory chickens. Atherosclerosis. 1989;75:105-109.
11. Verlangieri AJ, Bush M. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992;17:137-138.
12. Wojcicki J, Rozewicka L, Barcew-Wiszuiewska B, Samochawiec L, Juzwiak S, Kadubowaska D, Tustanowksi S, Juzszyn Z. Effect of selenium and vitamin E on the development of experimental atherosclerosis. Atherosclerosis 1991;87:9-19.
13. Singh RB, Niaz MA, Ghosh S, Agarwal P, Ahmad S, Beegom R, Onouchi Z, Kummerow FA. Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress and development of experimental atherosclerosis: The Diet and Antioxidant Trial on Atherosclerosis. Cardiovasc Drug Ther 1996;9:763-771.
14. Allain CC, Peon LS, Chan CS, Richmond W, Fu PC. Enzy- matic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
15. Finley PR, Schinan RB, William RJ, Liohti DA. Cholesterol in high density lipoprotein: Use of magnesium/dextran sulphate in its enzymatic measurement. Clin Chem 1978;24:931-933.
16. Friedwald WT, Levy RI, Fredrickson DS. Estimation of low density lipoprotein cholesterol concentration in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. Bucolo G, Devi H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;79:476482.
18. Lunec J, Hallovan SP, White AG, Dormandy TL. Free radical oxidation (peroxidation) products in serum and synovial fluids in rheumatoid arthritis. J Rheumatol 1981;8:233-245.
19. Vuilleurnier JP, Keller HE, Gysel D, Hunziker F. Clinical chemical methods for routine assessment of the vitamin status in human. Int J Vttam Nutr Res 1983;53:265-272.
20. Singh RB, Niaz MA, Ghosh S, Beegum R, Bishnoi I, Agarwal P, Agarwal A. Dietary intake and plasma levels of antioxidant vitamins in health and disease. A hospital based case control study. J Nutr Environ Med 1995;5:235-242.
21. Krltchevsky D, Tepper SA, Stary JA. Cholesterol vehicle in experimental atherosclerosis Part 16. Effect of peanut oil on preestablished lesions. Atherosclerosis 1978;31:365-370.
22. Kukreja RS, Dutta BN, Chakravarti RN. Catecholamine induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis 1981;40:291-298.
23. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brow MJ. Randomized controlled trial of vitamin E in patients with coronary artery disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347:781-786.
24. Singh RB, Niaz MA, Rastogi SS, Rastogi S. Usefulness of anti-oxidant vitamins in suspected acute myocardial infarction (The Indian Experiment of Infarct Survival-3). Am J Cardiol 1996;77:232-236.